+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

U.S. In-Vitro Fertilization (IVF) Market - Industry Outlook and Forecast 2021-2026

  • PDF Icon


  • 180 Pages
  • July 2021
  • Region: United States
  • Arizton
  • ID: 5380214
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this U.S. In-vitro Fertilization Market Report

The U.S. in-vitro fertilization market by revenue is expected to grow at a CAGR of 5.45% during the period 2021-2026.


Over the past few years, the infertility treatment market has been growing at a healthy rate because of rising awareness regarding the availability of various infertility treatment options through the government. Vendors advocating IVF awareness and campaigns are increasing the acceptance of IVF procedures and a surge in fertility tourism, which boosts the growth of the U.S. IVF market. Technological advancements and innovations are being majorly focused on by the fertility clinics and fertility treatment centers to improve the treatment outcomes, surging the growth of the IVF market. Some modern in-vitro fertilization technologies are assisted hatching, Cult-Active, EmbryoGen, Embryo glue, and Intracytoplasmic sperm injection. Investors are purchasing and acquiring fertility clinics with a high success rate of fertility treatment. New investors are discovering the attractiveness of infertility treatment after seeing the success of recent investments and establishing fertility clinics with sophisticated infrastructure.

The following factors are likely to contribute to the growth of the U.S. in-vitro fertilization market during the forecast period:
  • Technological Advancements & Innovations in IVF
  • Increasing Private Equity/Venture Capital Funding in IVF Clinics
  • Rising Number of Obesity Cases
  • Increasing Number of Fertility Clinics Offering Fertility Services

The study considers the present scenario of the U.S. In-vitro fertilization market and its market dynamics for the period 2020−2026. It covers a detailed overview of several market growth enablers, restraints, and trends.

The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent ones operating in the market.

  • The consumables segment is likely to witness the highest absolute growth of 43.16% in the U.S. in-vitro fertilization (IVF) market during the forecast period compared to media and equipment product segments.
  • As the market is witnessing the increased demand for infertility treatments, this created huge competition among the vendors to offer a wide range of innovative media, consumables, and the devices necessary for infertility treatment.
  • Japan, India, and the U.S. have a greater number of in-vitro fertilization clinics compared to other countries.


The U.S. in-vitro fertilization market research report will include in-depth coverage of the industry analysis with revenue and forecast insights for the following segments:

Segmentation by Products
  • Consumables
  • Media
  • Equipment

Segmentation by End-Users
  • Fertility Clinics
  • Hospitals
  • Others

Segmentation by Donor Type
  • Fresh Non-Donor
  • Frozen Non-Donor
  • Fresh Donor
  • Frozen Donor


The US in-vitro fertilization market is characterized by the presence of global, regional, and local vendors. In recent years, the global infertility treatment market has witnessed many strategic initiatives by key vendors, which is expected to intensify market competitiveness in the upcoming years. Infertility treatment is a niche industry with high margins for manufacturers, especially for vendors offering equipment, media, and related consumables, that are widely used during ART procedures. Players are expected to have active participation in the U.S. in-vitro fertilization market to maximize profit.

Prominent Vendors
  • The Cooper Companies
  • Cook Medical
  • Vitrolife
  • FUJIFILM Irvine Scientific
  • Merck Group
  • Hamilton Thorne

Other Prominent Vendors
  • Kitazato USA
  • Rocket Medical
  • Thermo Fisher Scientific
  • Thomas Medical
  • Nidacon
  • Esco Lifesciences


1. How big is the U.S. IVF market?
2. What is the growth rate of the US in vitro fertilization (IVF) market?
3. Which segment accounted for the largest in-vitro fertilization market share?
4. Who are the key players in the US in-vitro fertilization market?
5. What are some of the technological advancements and innovations in the IVF market?

Table of Contents

1 Research Methodology2 Research Objectives3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.1.3 Market Estimation Caveats
4.2 Base Year
4.3 Scope of the Study
4.3.1 Market Segmentation by Products
4.3.2 Market Segmentation by Procedures
4.3.3 Market Segmentation by End-Users
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Infertility Overview
7.2 IVF Treatment Overview
8 Market Opportunities & Trends
8.1 Technological Advances & Innovations in IVF
8.2 Single Parents & Same-Sex Couples Taking Infertility Treatments
8.3 Financial Assistance Programs & Employer Benefits for Infertility Treatment
8.4 Private Equity/Venture Capital Funding in IVF Clinics
9 Market Growth Enablers
9.1 Increasing Prevalence of Infertility
9.2 Rising Obesity Cases
9.3 Increasing Acceptance of Art Procedures
9.4 Rise in Number of Fertility Clinics
10 Market Restraints
10.1 Lack of Standardized Government Regulations
10.2 High Cost of IVF
10.3 Ethical Challenges Related to IVF Treatment
10.4 Limitations & Risks Associated with IVF Treatment
10.5 COVID-19 Adversely Impacting IVF Procedural Volumes
11 Market Landscape
11.1 Market Overview
11.2 Market Size & Forecast
11.2.1 Product Insights
11.2.2 End-Users Insights
11.2.3 Donor Type Insights
11.3 Five Forces Analysis
11.3.1 Threat of New Entrants
11.3.2 Bargaining Power of Suppliers
11.3.3 Bargaining Power of Buyers
11.3.4 Threat of Substitutes
11.3.5 Competitive Rivalry
12 Product
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Consumables
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.4 Media
12.4.1 Market Overview
12.4.2 Market Size & Forecast
12.5 Equipment
12.5.1 Market Overview
12.5.2 Market Size & Forecast
13 End-Users
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Fertility Clinics
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.4 Hospitals
13.4.1 Market Overview
13.4.2 Market Size & Forecast
13.5 Others
13.5.1 Market Overview
13.5.2 Market Size & Forecast
14 Donor Type
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Fresh Non-Donor
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.4 Frozen Non-Donor
14.4.1 Market Overview
14.4.2 Market Size & Forecast
14.5 Fresh Donor
14.5.1 Market Overview
14.5.2 Market Size & Forecast
14.6 Frozen Donor
14.6.1 Market Overview
14.6.2 Market Size & Forecast
15 Competitive Landscape
15.1 Competition Overview
15.2 Market Share Analysis
15.2.1 The Cooper Companies
15.2.2 Cook Medical
15.2.3 Vitrolife
15.2.4 FUJIFILM Irvine Scientific
15.2.5 Rocket Medical
15.2.7 Merck Group
15.2.8 Hamilton Thorne
16 Key Company Profiles
16.1 The Cooper Companies
16.1.1 Business Overview
16.1.2 Product Offerings
16.1.3 Key Strategies
16.1.4 Key Strengths
16.1.5 Key Opportunities
16.2 Cook Medical
16.2.1 Business Overview
16.2.2 Product Offerings
16.2.3 Key Strategies
16.2.4 Key Strengths
16.2.5 Key Opportunities
16.3 Vitrolife
16.3.1 Business Overview
16.3.2 Product Offerings
16.3.3 Key Strategies
16.3.4 Key Strengths
16.3.5 Key Opportunities
16.4 FUJIFILM Irvine Scientific
16.4.1 Business Overview
16.4.2 Product Offerings
16.4.3 Key Strategies
16.4.4 Key Strengths
16.4.5 Key Opportunities
16.5 Merck Group
16.5.1 Business Overview
16.5.2 Product Offerings
16.5.3 Key Strategies
16.5.4 Key Strengths
16.5.5 Key Opportunities
16.6 Hamilton Thorne
16.6.1 Business Overview
16.6.2 Product Offerings
16.6.3 Key Strategies
16.6.4 Key Strengths
16.6.5 Key Opportunities
17 Other Prominent Vendors
17.1.1 Business Overview
17.1.2 Product Offerings
17.2 Kitazato USA
17.2.1 Business Overview
17.2.2 Product Offerings
17.2.3 Key Strategies
17.2.4 Key Strengths
17.2.5 Key Opportunities
17.3 Rocket Medical
17.3.1 Business Overview
17.3.2 Product Offerings
17.3.3 Key Strategies
17.3.4 Key Strengths
17.3.5 Key Opportunities
17.4 Thermo Fisher Scientific
17.4.1 Business Overview
17.4.2 Product Offerings
17.4.3 Key Strategies
17.4.4 Key Strengths
17.5 Thomas Medical
17.5.1 Business Overview
17.5.2 Product Offerings
17.5.3 Key Strategies
17.6 Nidacon
17.6.1 Business Overview
17.6.2 Product Offerings
17.6.3 Key Strategies
17.6.4 Key Strengths
17.7 Esco Lifesciences
17.7.1 Business Overview
17.7.2 Product Offerings
17.7.3 Key Strategies
17.7.4 Key Strengths
17.8.1 Business Overview
17.8.2 Product Offerings
17.8.3 Key Strategies
17.8.4 Key Strengths
18 Report Summary
18.1 Key Takeaways
18.2 Strategic Recommendations
19 Quantitative Summary
19.1 Market by Product
19.2 Market by Donor Type
19.3 Market by End-Users
20 Appendix
20.1 Abbreviations

Companies Mentioned

  • The Cooper Companies
  • Cook Medical
  • Vitrolife
  • FUJIFILM Irvine Scientific
  • Merck Group
  • Hamilton Thorne
  • Kitazato USA
  • Rocket Medical
  • Thermo Fisher Scientific
  • Thomas Medical
  • Nidacon
  • Esco Lifesciences


Our research comprises a mix of primary and secondary research. The secondary research sources that are typically referred to include, but are not limited to, company websites, annual reports, financial reports, company pipeline charts, broker reports, investor presentations and SEC filings, journals and conferences, internal proprietary databases, news articles, press releases, and webcasts specific to the companies operating in any given market.

Primary research involves email interactions with the industry participants across major geographies. The participants who typically take part in such a process include, but are not limited to, CEOs, VPs, business development managers, market intelligence managers, and national sales managers. We primarily rely on internal research work and internal databases that we have populated over the years. We cross-verify our secondary research findings with the primary respondents participating in the study.